In addition to multiple myeloma cells, CS1 is expressed at low levels on other hematopoietic cells such as CD8+ T cells (35, 36).The non-specificity of the antigen may result in a poorer response to treatment of myeloma cells. The gene discussed is SLAMF7; the disease is plasma cell myeloma.